Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
GMO Manual

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

General Medical Officer (GMO) Manual: Clinical Section

Pneumonia

Department of the Navy
Bureau of Medicine and Surgery

Introduction

Diagnosis

Specific Therapy

Etiology

Radiographic Red Flags

Aspiration pneumonia

History and physical exam

Antibiotic therapy

Re-evaluation

Introduction

Pneumonia is the 5th most common cause of death and is a common infectious disease of lung parenchyma. Pneumonia is loosely divided into community acquired and nosocomial groups. Pneumonia that develops either during the hospital stay or within 4 to 6 weeks after discharge from the hospital, in the nursing home or in long-term care facilities, is considered nosocomial pneumonia. Pneumonia that develops in other settings is called community acquired pneumonia. Community acquired pneumonia is further divided into acute bacterial pneumonia and atypical pneumonia.

Etiology

The common causes of community acquired pneumonia are Pneumococcus, Hemophilus influenzae, Legionella (bacterial), Mycoplasma, and Chlamydia. Other uncommon causes of community acquired pneumonia are Group A Streptococcus, Staph aureus, gram-negative rods, Moraxella catarrhalis (smokers), and anaerobes (aspiration). Other rare causes of pneumonia based on endemic areas are Coccidiomycosis, histoplasmosis, Blastomycosis, and Rickettsia. Finally consider Pneumocystis carinii pneumonia (PCP) and tuberculosis (TB) in immunosuppressed patients.

Clues from the history and physical exam

With pleuritic type chest pain, suspect a pleural effusion; rigors are more common with pneumococcal lung infection. Check the respiratory rate and observe the patient closely if above 25. Check tilts to assess whether the patient is dehydrated. Check the oxygen saturation. Hemoptysis (blood tinged sputum) is rare with Mycoplasma pneumonia but is often seen with bacterial, TB, and fungal type lung infections. Severe coughing spells and wheezing in a non-asthmatic is suggestive of chlamydia. Associated headache and GI symptoms suggest Legionella.

Diagnosis

After gathering the history and performing the physical exam, request a CBC, chemistry studies, CXR, and sputum smear. Always check a pulse oximetry. If a pulse oximetry is not available, place the patient on oxygen. Initiate IV hydration.

A WBC of < 3,000/mm3 or > 25,000 is an ominous sign. A respiratory rate >30, a diastolic blood pressure < 60 mmHg, and a BUN > 20 are other poor prognostic signs. If you suspect tuberculosis based upon clinical and/or radiographic features, ISOLATE the patient immediately. Do not hesitate when in doubt.

Perform a sputum gram stain. If the gram stain demonstrates gram positive organisms suggestive of Pneumococcus or Streptococci, begin a third generation cephalosporin such as Ceftriaxone or Cefuroxime. If either antibiotic is not available, penicillin may be given at a dosage schedule of 2 million units every 4 hours (IV). If a sputum sample is not available or the gram stain is not helpful, begin empiric therapy with Ceftriaxone (or Cefuroxime) and Azithromycin. If the gram stain demonstrates gram-negative cocco-bacillary forms, begin Ceftriaxone, Cefuroxime or Septra.

Radiographic Red Flags

  • Volume loss – This implies endobronchial obstruction (i.e. foreign body, anatomical abnormalities, or tumor). The patient needs bronchoscopy and isolation.

  • Pleural effusion – Look at the costophrenic angle. If this is obliterated, request lateral decubitus x-ray views. If the fluid layers out to more than 10mm, a thoracentesis should be performed to determine the cause. If clinical deterioration occurs, tap the fluid even if it is <10mm.

  • Adenopathy - Hilar and mediastinal adenopathy signify an atypical pneumonia. Suspicion for organisms such as tuberculosis or fungi should be high. Isolate the patient and do an aggressive workup for diagnosis.

  • Cavitation – The most common community acquired pneumonias rarely cavitate except Staph aureus pneumonia. When cavitation is seen, isolate the patient. Suspect tuberculosis, aspiration pneumonia, and a fungal infection.

  • Multilobar involvement – When more than two lobes are involved, this signifies high mortality in pneumonia.

  • Progression of pneumonia while on antibiotics – Suspect TB, fungal, PCP, or Legionella as the etiology.

RED FLAGS require aggressive diagnostic, therapeutic management, and early transfer or MEDEVAC.

Antibiotic therapy

The following description outlines empiric therapy for outpatient CAP:

In patients with comorbidities such as smoking, alcoholism or those older than 60, consider coverage for H. influenzae with the addition of a second generation cephalosporin:

  • Cefuroxime (Ceftin) 500mg, one PO BID, or

  • Cefpodoxime (Vantin) 200mg, one PO BID, or

  • Augmentin 500mg, one PO TID, or 875mg, one PO TID, or

  • Septra DS, one PO BID.

If the patient requires hospitalization, use the same antibiotic agents; a macrolide with a second or third generation cephalosporin such as Ceftriaxone (Rocephin 2 gm IV QD), or Cefuroxime 1.5 gm IV, every 8 hours.

Specific Therapy

Aspiration pneumonia

This can occur after dental work or drinking alcohol. Clues can include bad smelling or tasting sputum, night sweats, and mild anemia. Treatment choices include Timentin IV, Unisyn IV, Augmentin PO or Clindamycin PO.

Re-evaluation

Once therapy is started, daily clinical reevaluation is necessary to ensure a good response to therapy. The chest x-ray findings may lag behind the clinical response but should be obtained in 2-3 weeks to ensure complete resolution of the infiltrate.

Reviewed by CAPT Angeline A. Lazararus, MC, USN, Pulmonary Specialty Leader, Department of Internal Medicine, National Naval Medical Center, Bethesda, MD (1999).


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

 

Advertise on this site